IntelliCyt^® Biologics Discovery program takes aim on antibody screening

The  HTFC Screening System and our “mix-and-measure” intact cell assay for primary screening simultaneously assesses antigen binding and cross-reactivity with higher throughput, greater sensitivity and dynamic range.

• measures cells in suspension, so epitopes can be measured in their native state
• reduces workflow steps and increases productivity
• reads a 384-well plate in under 15 minutes.

IntelliCyt customers report up to a 24X increase in throughput, dramatically increasing their opportunity for success in discovering antibodies to treat cancer, cardiovascular disease, diabetes, autoimmune diseases or AIDS. More Information»